| pubmed-article:1846495 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1846495 | lifeskim:mentions | umls-concept:C0206435 | lld:lifeskim |
| pubmed-article:1846495 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:1846495 | lifeskim:mentions | umls-concept:C0815000 | lld:lifeskim |
| pubmed-article:1846495 | lifeskim:mentions | umls-concept:C0596988 | lld:lifeskim |
| pubmed-article:1846495 | lifeskim:mentions | umls-concept:C0205322 | lld:lifeskim |
| pubmed-article:1846495 | lifeskim:mentions | umls-concept:C1707391 | lld:lifeskim |
| pubmed-article:1846495 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:1846495 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1846495 | pubmed:dateCreated | 1991-2-22 | lld:pubmed |
| pubmed-article:1846495 | pubmed:abstractText | Six Sabin-derived persistent poliovirus mutants were selected in human neuroblastoma IMR-32 cells. The mutants had a titer 30 to 10(5) times lower in nonneural HEp-2c cells than in IMR-32 cells. When the growth cycles of persistent viruses in the two cell lines were compared, the most striking feature was a delay of 2 to 4 hr in virus release from HEp-2c cells. In Hep-2c cells, type 1 mutants could spontaneously establish a persistent infection in the absence of any exogenous viral inhibitor. Mutations at a rate of 1 every 210 nucleotides had accumulated in the genome of the type 1 mutants selected in neuroblastoma cells, modifying cell specificity and conferring the ability to persist in some nonneural cells. These results indicate that mutants of poliovirus with highly modified biological properties can be selected in vitro in cells of neural origin. | lld:pubmed |
| pubmed-article:1846495 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1846495 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1846495 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1846495 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1846495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1846495 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1846495 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:1846495 | pubmed:issn | 0042-6822 | lld:pubmed |
| pubmed-article:1846495 | pubmed:author | pubmed-author:CrainicRR | lld:pubmed |
| pubmed-article:1846495 | pubmed:author | pubmed-author:EhrenfeldEE | lld:pubmed |
| pubmed-article:1846495 | pubmed:author | pubmed-author:Colbere-Garap... | lld:pubmed |
| pubmed-article:1846495 | pubmed:author | pubmed-author:CoudercTT | lld:pubmed |
| pubmed-article:1846495 | pubmed:author | pubmed-author:PelletierII | lld:pubmed |
| pubmed-article:1846495 | pubmed:author | pubmed-author:BorzakianSS | lld:pubmed |
| pubmed-article:1846495 | pubmed:author | pubmed-author:WyckoffEE | lld:pubmed |
| pubmed-article:1846495 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1846495 | pubmed:volume | 180 | lld:pubmed |
| pubmed-article:1846495 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1846495 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1846495 | pubmed:pagination | 729-37 | lld:pubmed |
| pubmed-article:1846495 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:meshHeading | pubmed-meshheading:1846495-... | lld:pubmed |
| pubmed-article:1846495 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1846495 | pubmed:articleTitle | Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. | lld:pubmed |
| pubmed-article:1846495 | pubmed:affiliation | Unité de Virologie Médicale, Institut Pasteur, Paris, France. | lld:pubmed |
| pubmed-article:1846495 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1846495 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1846495 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1846495 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1846495 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1846495 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1846495 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1846495 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1846495 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1846495 | lld:pubmed |
